Institut de Cancérologie de Lorraine
↗Vandœuvre-lès-Nancy, France
The Institut de Cancérologie de Lorraine (ICL) is the sole hospital establishment in the Lorraine region of France dedicated entirely to cancer diagnosis, treatment, and research. Founded in 1924 by Dr. Alexis Vautrin as a specialized oncology facility, it evolved from its original radium treatment focus to become a comprehensive cancer center serving 17,000 patients annually. As a private health establishment of collective interest (ESPIC) and member of Unicancer (the national federation of French comprehensive cancer centers), the ICL provides standard and highly specialized care across all major cancer types. The institute combines clinical care, teaching, and research, operating as a regional cancer control center in collaboration with the Nancy University Hospital (CHRU).
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Healthcare - Oncology
Sub-Industry:Comprehensive Cancer Center - Clinical Care & Research
SIZE & FINANCIALS
Employees:501-1000
Revenue:€26 million (reported figure, year unspecified)
Founded:1924
Ownership:nonprofit
Status:operating
FUNDING
Total Raised:€68 million (EPOnA project 2024-2027)
Investors:Regional Health Authority (ARS Grand Est) - €28 million for EPOnA project
PIPELINE
Stage:Clinical Care & Translational Research
Lead Drug Stage:Not applicable - clinical center, not drug developer
Modalities:Radiotherapy (6 linacs including CyberKnife), Chemotherapy, Surgical Oncology, HDR-BT (Brachytherapy), Prostate Seed Implants, Medical Imaging
Active Trials:1120
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Unicancer (French comprehensive cancer center network - member), NEON health network (Eastern France regional network), Cancéropôle Est (molecular diagnosis and liquid biopsy coordination), Nancy University Hospital (CHRU) - Regional Cancer Center coordination, MVision AI (Guide and Verify radiotherapy solutions - 2024), RaySearch Laboratories (RayStation treatment planning system - 2024), BioValley France (life sciences network), OECI - Organization of European Cancer Institutes (member)
COMPETITION
Position:Leader - Ranked #1 hospital in Grand Est region, #125 worldwide in Newsweek 2025 Best Specialized Hospitals ranking for oncology
Competitors:Institut de Cancérologie de Strasbourg Europe (ICANS), Institut Bergonié (Bordeaux), Institut Curie (Paris), Centre Oscar Lambret (Lille), Other Unicancer network members
LEADERSHIP
Key Executives:
Prof. Didier PEIFFERT - Director General
Dr. S. GOLFOUSE - President of Medical Committee
Scientific Founders:Dr. Alexis Vautrin
Board Members:Prefect of Meurthe-et-Moselle (Board President), Yves SEGUY (Board Member), Arnaud VANNESTE (Board Member), Hubert ATTENONT (Board Member), Jean-Maurice PUGIN (Board Member), Dr. Benoit HOMBOURGER (Board Member)
LINKS
Website:nancy.unicancer.fr
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Institut de Cancérologie de Lorraine. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.